Cryo-Cell International Inc. (CCEL)
Stock Price: $8.74 USD
0.09 (1.04%)
Updated Feb 25, 2021 9:30 AM EST - Market open
| Market Cap | 65.27M |
| Revenue (ttm) | 31.58M |
| Net Income (ttm) | 3.27M |
| Shares Out | 7.55M |
| EPS (ttm) | 0.40 |
| PE Ratio | 21.85 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 25 |
| Last Price | $8.74 |
| Previous Close | $8.65 |
| Change ($) | 0.09 |
| Change (%) | 1.04% |
| Day's Open | 8.74 |
| Day's Range | 8.74 - 8.74 |
| Day's Volume | 100 |
| 52-Week Range | 5.5 - 9.93 |
News
There are no news available yet.
About CCEL
Cryo-Cell International engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process... [Read more...]
| Industry Medical Care Facilities | IPO Date Jan 21, 1997 |
| CEO David I. Portnoy | Employees 87 |
| Stock Exchange OTCMKTS | Ticker Symbol CCEL |